ELESSE Trademark

Trademark Overview


On Thursday, May 8, 2025, a trademark application was filed for ELESSE with the United States Patent and Trademark Office. The USPTO has given the ELESSE trademark a serial number of 99176068. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, September 25, 2025. This trademark is owned by Perfero Pharma, Inc.. The ELESSE trademark is filed in the Cosmetics & Cleaning Products category with the following description:

non-medicated product for use in the treatment of female health conditions
elesse

General Information


Serial Number99176068
Word MarkELESSE
Filing DateThursday, May 8, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, September 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesnon-medicated product for use in the treatment of female health conditions

Classification Information


International Class003 - Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices.
US Class Codes001, 004, 006, 050, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 8, 2025
Primary Code003
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePerfero Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRoseland, NJ 07068

Trademark Events


Event DateEvent Description
Thursday, May 8, 2025NEW APPLICATION ENTERED
Thursday, May 8, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, September 17, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 24, 2025ASSIGNED TO EXAMINER
Thursday, September 25, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 25, 2025NON-FINAL ACTION E-MAILED
Thursday, September 25, 2025NON-FINAL ACTION WRITTEN